Literature DB >> 16730861

Tissue-specific modulation of angiotensin-converting enzyme (ACE) in hyperthyroidism.

M S Carneiro-Ramos1, V B Silva, R A S Santos, M L M Barreto-Chaves.   

Abstract

We have previously demonstrated the interaction between the RAS and thyroid hormones (TH). The present study was designed to determine the role of TH in the local regulation of ACE activity and expression in different tissues. Adult male Wistar rats were randomized into three groups: T4-25 and T4-100 (0.025 and 0.100mg/kg of body weight/day of l-thyroxine for 14 days, respectively) and control. Hemodynamic parameters as well as cardiac and renal hypertrophy were evaluated. ACE activity and mRNA levels were determined by Fluorimetric and Northern blot assays, respectively. Both doses increased SBP and HR, as well as inducing cardiac and renal hypertrophy. Pulmonary and serum ACE levels were comparable among the groups. Both doses promoted increased renal ACE activity and expression but surprisingly ACE was diminished in the heart in both hyperthyroid groups. This change was mediated by a tissue-specific transcription mechanism.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16730861     DOI: 10.1016/j.peptides.2006.04.015

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  7 in total

1.  Angiotensin type 1 (AT1) and type 2 (AT2) receptors mediate the increase in TGF-beta1 in thyroid hormone-induced cardiac hypertrophy.

Authors:  G P Diniz; M S Carneiro-Ramos; M L M Barreto-Chaves
Journal:  Pflugers Arch       Date:  2007-01-06       Impact factor: 3.657

2.  Cardiac ACE2/angiotensin 1-7/Mas receptor axis is activated in thyroid hormone-induced cardiac hypertrophy.

Authors:  Gabriela P Diniz; Nathalia Senger; Marcela S Carneiro-Ramos; Robson A S Santos; Maria Luiza M Barreto-Chaves
Journal:  Ther Adv Cardiovasc Dis       Date:  2015-12-28

3.  Decreased number of circulating endothelial progenitor cells in patients with Graves' hyperthyroidism.

Authors:  C De Ciuceis; A Pilu; C Cappelli; E Porteri; F Zani; A Santoro; E Gandossi; G E M Boari; N Rizzardi; M Castellano; D Rizzoni; E Agabiti Rosei
Journal:  J Endocrinol Invest       Date:  2010-06-28       Impact factor: 4.256

4.  Cardiac angiotensin II type I and type II receptors are increased in rats submitted to experimental hypothyroidism.

Authors:  M S Carneiro-Ramos; G P Diniz; J Almeida; R L P Vieira; S V B Pinheiro; R A Santos; M L M Barreto-Chaves
Journal:  J Physiol       Date:  2007-05-31       Impact factor: 5.182

5.  Aliskiren, Fosinopril, and Their Outcome on Renin-Angiotensin-Aldosterone System (RAAS) in Rats with Thyroid Dysfunction.

Authors:  Susan A S Farhadi; Kawa F Dizaye
Journal:  Int J Endocrinol       Date:  2019-07-18       Impact factor: 3.257

Review 6.  The Role of Thyroid Diseases and their Medications in Cardiovascular Disorders: A Review of the Literature.

Authors:  Negar Omidi; Mohammadrafie Khorgami; Farbod Z Tajrishi; Amirhosein Seyedhoseinpour; Parichehr Pasbakhsh
Journal:  Curr Cardiol Rev       Date:  2020

Review 7.  Prospective role of thyroid disorders in monitoring COVID-19 pandemic.

Authors:  Kanchan Kumari; Gagan B N Chainy; Umakanta Subudhi
Journal:  Heliyon       Date:  2020-12-13
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.